生物活性 | |||
---|---|---|---|
描述 | KM11060 is a corrective agent for the F508 deletion (F508del) in the cystic fibrosis transmembrane conductance regulator (CFTR), aiming to address the trafficking malfunction associated with this mutation. This compound has applications in researching the F508del-CFTR processing anomaly and contributes to the advancement of cystic fibrosis studies[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.37mL 0.47mL 0.24mL |
11.84mL 2.37mL 1.18mL |
23.68mL 4.74mL 2.37mL |
参考文献 |
---|